Dr. Robert Orlowski, myeloma expert, explains how the recent FDA approval of Pomalyst (pomalidomide) gives advanced myeloma patients more treatment options, increasing hope. Dr. Orlowski explains what this means and how this changes the way myeloma is treated moving forward.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…